幹細胞製造の世界市場:製品別(消耗品、器具、幹細胞ライン)、用途別(研究用途、臨床用途、細胞・組織バンク)、エンドユーザー別(製薬・バイオ企業、学術機関、研究所・CRO、病院・手術センター、細胞・組織バンク、その他)、地域別(北米、中南米、欧州、アジア太平洋、中東、アフリカ)-2023年から2033年までGlobal Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), by Application (Research Applications, Clinical Application, Cell & Tissue Banking), by End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories & CROs, Hospital & Surgical Centres, Cell & Tissue Banks, Others), by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa ) - 2023 to 2033 幹細胞製造市場 - レポートのスコープ TMRの調査レポート「世界の幹細胞製造市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会... もっと見る
このレポートは受注生産にて作成するため
サマリー幹細胞製造市場 - レポートのスコープTMRの調査レポート「世界の幹細胞製造市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2033年を予測年として、2017年から2033年までの期間における世界の幹細胞製造市場の収益を提供しています。また、2023年から2033年までの世界の幹細胞製造市場の複合年間成長率(CAGR %)を掲載しています。 本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査の大部分を行った。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、幹細胞製造市場を把握した。 二次調査には、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれる。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の幹細胞製造市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、世界の幹細胞製造市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場関係者だけでなく、世界の幹細胞製造市場への参入を検討している企業にとっても、貴重なツールとなります。 本レポートは、世界の幹細胞製造市場の競争環境について掘り下げています。世界の幹細胞製造市場で活動する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の幹細胞製造市場のプレーヤーの属性です。 世界の幹細胞製造市場レポートで回答された主要な質問 - 予測期間中、全地域における幹細胞製造の売上/収益はどの程度か? - 世界の幹細胞製造市場におけるビジネスチャンスは何か? - 市場における主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大するのはどの地域市場か? - 2033年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか? - 世界市場で事業展開している各社の市場ポジションは? 幹細胞製造市場 - 研究目的と研究アプローチ 幹細胞製造の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明しています。本調査の目的、市場で活動する主要ベンダーや流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。 本レポートでは、世界の幹細胞製造市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2033年末時点の各セグメントごとの市場シェアを掲載しています。このような貴重な洞察により、市場関係者は、世界の幹細胞製造市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast, 2023-2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033 5.3.1. Consumables 5.3.1.1. Culture Media 5.3.1.2. Other Consumables 5.3.2. Hematopoietic Stem Cells 5.3.2.1. Mesenchymal Stem Cells 5.3.2.2. Induced Pluripotent Stem Cells 5.3.2.3. Embryonic Stem Cells 5.3.2.4. Neural Stem Cells 5.3.2.5. Multipotent Adult Progenitor Stem Cells 5.3.3. Instruments 5.3.3.1. Bioreactor and Incubator 5.3.3.2. Cell Sorter 5.3.3.3. Other Instruments 5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022 5.5. Absolute $ Opportunity Analysis By Product, 2023-2033 6. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033 6.3.1. Research Applications 6.3.1.1. Life Science Research 6.3.1.2. Drug Discovery and Development 6.3.2. Clinical Application 6.3.2.1. Allogenic Stem Cell Therapy 6.3.2.2. Autologous Stem Cell Therapy 6.3.3. Cell & Tissue Banking 6.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022 6.5. Absolute $ Opportunity Analysis By Application, 2023-2033 7. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033 7.3.1. Pharmaceutical & Biotechnology Companies 7.3.2. Academic Institutes, Research Laboratories & CROs 7.3.3. Hospital & Surgical Centers 7.3.4. Cell & Tissue Banks 7.3.5. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022 7.5. Absolute $ Opportunity Analysis By End User, 2023-2033 8. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 11.2.1. By Country 11.2.1.1. U.K. 11.2.1.2. Spain 11.2.1.3. Germany 11.2.1.4. Italy 11.2.1.5. France 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Rest of Asia Pacific 12.2.2. By Product 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. Middle East and Africa Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 13.2.1. By Country 13.2.1.1. South Africa 13.2.1.2. GCC Countries 13.2.1.3. Rest of Middle East and Africa 13.2.2. By Product 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Stem Cell Manufacturing Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Product 14.1.2.2. By Application 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Product 14.2.2.2. By Application 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Product 14.3.2.2. By Application 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Product 14.4.2.2. By Application 14.4.2.3. By End User 14.5. U.K. 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Product 14.5.2.2. By Application 14.5.2.3. By End User 14.6. Spain 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Product 14.6.2.2. By Application 14.6.2.3. By End User 14.7. Germany 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Product 14.7.2.2. By Application 14.7.2.3. By End User 14.8. Italy 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Product 14.8.2.2. By Application 14.8.2.3. By End User 14.9. France 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Product 14.9.2.2. By Application 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Product 14.10.2.2. By Application 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Product 14.11.2.2. By Application 14.11.2.3. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Product 14.12.2.2. By Application 14.12.2.3. By End User 14.13. South Africa 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Product 14.13.2.2. By Application 14.13.2.3. By End User 14.14. GCC Countries 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Product 14.14.2.2. By Application 14.14.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Thermo Fisher Scientific 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Merck Millipore 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Lonza Group AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Danaher Corporation 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Sartorius AG 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Bio-Rad Laboratories 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Becton, Dickinson and Company 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. Stemcell Technologies 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Fujifilm Holdings Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Miltenyi Biotech 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.11. Terumo Corporation 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.12. Corning Inc. 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.13. Bio-Techno Corporation 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.14. Takara Bio Group 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.15. Eppendorf AG 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology 図表リストList of TablesTable 1: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by Region, 2018-2033 Table 2: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 3: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 4: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 5: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 6: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 7: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 8: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 9: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 10: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 11: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 12: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 13: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 14: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 15: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 16: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 17: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 18: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 19: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 20: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 21: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 22: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 23: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 24: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033
SummaryStem Cell Manufacturing Market – Scope of Report Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast, 2023-2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033 5.3.1. Consumables 5.3.1.1. Culture Media 5.3.1.2. Other Consumables 5.3.2. Hematopoietic Stem Cells 5.3.2.1. Mesenchymal Stem Cells 5.3.2.2. Induced Pluripotent Stem Cells 5.3.2.3. Embryonic Stem Cells 5.3.2.4. Neural Stem Cells 5.3.2.5. Multipotent Adult Progenitor Stem Cells 5.3.3. Instruments 5.3.3.1. Bioreactor and Incubator 5.3.3.2. Cell Sorter 5.3.3.3. Other Instruments 5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022 5.5. Absolute $ Opportunity Analysis By Product, 2023-2033 6. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033 6.3.1. Research Applications 6.3.1.1. Life Science Research 6.3.1.2. Drug Discovery and Development 6.3.2. Clinical Application 6.3.2.1. Allogenic Stem Cell Therapy 6.3.2.2. Autologous Stem Cell Therapy 6.3.3. Cell & Tissue Banking 6.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022 6.5. Absolute $ Opportunity Analysis By Application, 2023-2033 7. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033 7.3.1. Pharmaceutical & Biotechnology Companies 7.3.2. Academic Institutes, Research Laboratories & CROs 7.3.3. Hospital & Surgical Centers 7.3.4. Cell & Tissue Banks 7.3.5. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022 7.5. Absolute $ Opportunity Analysis By End User, 2023-2033 8. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 11.2.1. By Country 11.2.1.1. U.K. 11.2.1.2. Spain 11.2.1.3. Germany 11.2.1.4. Italy 11.2.1.5. France 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Rest of Asia Pacific 12.2.2. By Product 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. Middle East and Africa Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 13.2.1. By Country 13.2.1.1. South Africa 13.2.1.2. GCC Countries 13.2.1.3. Rest of Middle East and Africa 13.2.2. By Product 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Stem Cell Manufacturing Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Product 14.1.2.2. By Application 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Product 14.2.2.2. By Application 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Product 14.3.2.2. By Application 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Product 14.4.2.2. By Application 14.4.2.3. By End User 14.5. U.K. 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Product 14.5.2.2. By Application 14.5.2.3. By End User 14.6. Spain 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Product 14.6.2.2. By Application 14.6.2.3. By End User 14.7. Germany 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Product 14.7.2.2. By Application 14.7.2.3. By End User 14.8. Italy 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Product 14.8.2.2. By Application 14.8.2.3. By End User 14.9. France 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Product 14.9.2.2. By Application 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Product 14.10.2.2. By Application 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Product 14.11.2.2. By Application 14.11.2.3. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Product 14.12.2.2. By Application 14.12.2.3. By End User 14.13. South Africa 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Product 14.13.2.2. By Application 14.13.2.3. By End User 14.14. GCC Countries 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Product 14.14.2.2. By Application 14.14.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Thermo Fisher Scientific 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Merck Millipore 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Lonza Group AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Danaher Corporation 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Sartorius AG 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Bio-Rad Laboratories 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Becton, Dickinson and Company 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. Stemcell Technologies 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Fujifilm Holdings Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Miltenyi Biotech 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.11. Terumo Corporation 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.12. Corning Inc. 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.13. Bio-Techno Corporation 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.14. Takara Bio Group 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.15. Eppendorf AG 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology List of Tables/GraphsList of TablesTable 1: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by Region, 2018-2033 Table 2: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 3: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 4: Global Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 5: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 6: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 7: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 8: North America Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 9: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 10: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 11: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 12: Latin America Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 13: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 14: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 15: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 16: Europe Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 17: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 18: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 19: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 20: Asia Pacific Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033 Table 21: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by Country, 2018-2033 Table 22: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by Product, 2018-2033 Table 23: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by Application, 2018-2033 Table 24: Middle East and Africa Stem Cell Manufacturing Market Value (US$ Million) Forecast by End User, 2018-2033
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Transparency Market Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD(stem cell)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |